. Author manuscript; available in PMC: 2018 Feb 27.

Published in final edited form as: Ann Surg Oncol. 2011 Aug 12;19(Suppl 3):S483–S490. doi: 10.1245/s10434-011-1971-1

TABLE 1.

MDA1986 Nu/Nu treatment response based on modified RECIST criteria

Tx group	Animal no. 1	Animal no. 2	Animal no. 3	Animal no. 4	Animal no. 5	Animal no. 6	Animal no. 7	Animal no. 8
Control	PD	PD	PD	PD	PD	PD	PD	PD
5 mg/kg KU363	PR	CR	PR	PR	PR	PR	SD	SD
25 mg/kg KU363	CR	CR	PR	SD	PR	CR	PR	PR
17-AAG	PR	PR	PD	PR	PR	SD	PR	SD
Cisplatin	PR	PR	CR	CR	CR	CR	CR	CR

Percentages are obtained by comparison of final tumor volume to tumor volume at time of first treatment

CR complete response, PR partial response (>30% reduction in tumor volume), SD stable disease (<30% reduction in tumor volume or <30% growth in tumor volume), PD progressive disease (>30% growth in tumor volume)